ANBL1531: A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALKInhibitor Therapy in Children with Newly Diagnosed High-Risk NBL

Williams, Robin L (PI)
Greengard, Emily G (Prior Principal Investigator)
Weigel, Brenda J (Prior Principal Investigator)

Pediatric Hematology/Oncology

Project: Research project

Description

ANBL1531: A Phase 3 Study of 131I-Metaiodobenzylguanidine (131I-MIBG) or ALK Inhibitor Therapy in Children with Newly Diagnosed High-Risk NBL

Status	Active
Effective start/end date	1/1/22 → 12/31/26

Funding

PUBLIC HEALTH INSTITUTE
PFIZER, INC.